Japanese drugmaker Takeda Pharmaceutical Co. on Thursday said it is developing a vaccine to prevent the Zika virus, which has been linked to severe birth defects, and has secured funding from a U.S. government agency. Takeda, which is also working on vaccines for other mosquito-borne ...
The Obama administration warned Congress Wednesday that money to fight the Zika virus is on the verge of running out amid political stalemate on Capitol Hill. In a letter to key lawmakers, the secretary of Health and Human Services said the National Institutes of Health ...
A type of experimental vaccine that can be made in just a week and has protected mice against influenza, Ebola and Zika viruses may offer promise for quick responses to disease outbreaks in people, according to Massachusetts Institute of Technology researchers. MIT scientists said their ...
Sixty-three women and girls who reported side effects from cervical cancer vaccines sued the government and drugmakers on Wednesday as a sharp divide remained over the risks the medicine poses. The plaintiffs, ranging in age from 15 to 22, filed suits in district courts in ...
French drugmaker Sanofi said on Wednesday it had struck a research and development deal with the U.S. Army to speed up the development of a vaccine against the mosquito-borne Zika virus. Sanofi is the only major drugmaker working on a vaccine against Zika, which has ...
Victims suffering side effects from cervical cancer vaccines that were once recommended by the government announced Wednesday they will file a lawsuit against the state and drugmakers. "Many victims are still suffering from side effects of the human papillomavirus (HPV) vaccines Cervarix and Gardsil, which ...
The Zika virus could spread to Africa, Asia and Southern Europe, the World Health Organization said on Tuesday, as major French drugmaker Sanofi SA and others joined the race to create a vaccine. A day after Geneva-based WHO declared an international public health emergency due ...
The first vaccine against dengue fever won clearance in Mexico, an initial step toward preventing a mosquito-borne infection that puts half of the world's population at risk. Sanofi expects more approvals in "upcoming weeks" for the product, called Dengvaxia, in Latin America and Asia, Olivier ...
Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable people — babies and senior citizens. If further testing by vaccine developer Novavax Inc. goes well, in a ...
Scientists have discovered new antibodies that neutralize viruses that cause dengue, potentially putting a universal vaccine within reach for a mosquito-borne illness that strikes an estimated 400 million people a year. The antibodies are effective against all four dengue viruses, according to an article published ...
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which began ...
Fujifilm Corp. said Monday it will acquire U.S. vaccine maker Kalon Biotherapeutics LLC to expand its biopharmaceutical business, with the Tokyo-based firm already having gained prominence for offering a possible treatment for Ebola patients. A Fujifilm subsidiary in the United States last Wednesday signed an ...
